Microduplications at the 15Q11.2 BP1–BP2 Locus Are Enriched in Patients with Anorexia Nervosa T
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights Into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle
animals Article Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle Masoumeh Naserkheil 1 , Abolfazl Bahrami 1 , Deukhwan Lee 2,* and Hossein Mehrban 3 1 Department of Animal Science, University College of Agriculture and Natural Resources, University of Tehran, Karaj 77871-31587, Iran; [email protected] (M.N.); [email protected] (A.B.) 2 Department of Animal Life and Environment Sciences, Hankyong National University, Jungang-ro 327, Anseong-si, Gyeonggi-do 17579, Korea 3 Department of Animal Science, Shahrekord University, Shahrekord 88186-34141, Iran; [email protected] * Correspondence: [email protected]; Tel.: +82-31-670-5091 Received: 25 August 2020; Accepted: 6 October 2020; Published: 9 October 2020 Simple Summary: Hanwoo is an indigenous cattle breed in Korea and popular for meat production owing to its rapid growth and high-quality meat. Its yearling weight and carcass traits (backfat thickness, carcass weight, eye muscle area, and marbling score) are economically important for the selection of young and proven bulls. In recent decades, the advent of high throughput genotyping technologies has made it possible to perform genome-wide association studies (GWAS) for the detection of genomic regions associated with traits of economic interest in different species. In this study, we conducted a weighted single-step genome-wide association study which combines all genotypes, phenotypes and pedigree data in one step (ssGBLUP). It allows for the use of all SNPs simultaneously along with all phenotypes from genotyped and ungenotyped animals. Our results revealed 33 relevant genomic regions related to the traits of interest. -
Variable Penetrance of the 15Q11.2 BP1–BP2 Microduplication in a Family With
bioRxiv preprint doi: https://doi.org/10.1101/095919; this version posted December 22, 2016. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Variable penetrance of the 15q11.2 BP1–BP2 microduplication in a family with cognitive and language impairment Antonio Benítez-Burraco1, Montserrat Barcos-Martínez 2,3, Isabel Espejo-Portero2,3, Mª Salud Jiménez-Romero2,4 1. Department of Philology, University of Huelva, Huelva, Spain 2. Maimónides Institute of Biomedical Research, Córdoba, Spain 3. Laboratory of Molecular Genetics, University Hospital “Reina Sofía”, Córdoba, Spain 4. Department of Psychology, University of Córdoba, Córdoba, Spain Corresponding author: Antonio Benítez-Burraco Área de Lengua Española. Departamento de Filología. Facultad de Humanidades. Campus de "El Carmen". Universidad de Huelva. Avda. de las Fuerzas Armadas s/n. 21071-Huelva (España) e-mail: [email protected] Contact details for the other authors: Mª Salud Jiménez-Romero: [email protected] Montserrat Barcos-Martínez: [email protected] Isabel Espejo-Portero: [email protected] bioRxiv preprint doi: https://doi.org/10.1101/095919; this version posted December 22, 2016. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 2 ABSTRACT The 15q11.2 BP1–BP2 region is found duplicated or deleted in people with cognitive, language, and behavioral impairment. Case presentation. We report on a family (the father and three male twin siblings) who presents with a duplication of the 15q11.2 BP1-BP2 region and a variable phenotype: whereas the father and the fraternal twin are normal carriers, the monozygotic twins exhibit severe language and cognitive delay and behavioral disturbances. -
Association of NIPA1 Repeat Expansions with Amyotrophic Lateral Sclerosis in a Large International Cohort
This is a repository copy of Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/138180/ Version: Accepted Version Article: Tazelaar, G.H.P., Dekker, A.M., van Vugt, J.J.F.A. et al. (28 more authors) (2018) Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort. Neurobiology of Aging. ISSN 0197-4580 https://doi.org/10.1016/j.neurobiolaging.2018.09.012 Reuse This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) licence. This licence only allows you to download this work and share it with others as long as you credit the authors, but you can’t change the article in any way or use it commercially. More information and the full terms of the licence here: https://creativecommons.org/licenses/ Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ Accepted Manuscript Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort Gijs HP. Tazelaar, Annelot M. Dekker, Joke JFA. van Vugt, Rick A. van der Spek, Henk-Jan Westeneng, Lindy JBG. Kool, Kevin P. Kenna, Wouter van Rheenen, Sara L. Pulit, Russell L. McLaughlin, William Sproviero, Alfredo Iacoangeli, Annemarie Hübers, David Brenner, Karen E. -
Hereditary Spastic Paraplegias
Hereditary Spastic Paraplegias Authors: Doctors Enza Maria Valente1 and Marco Seri2 Creation date: January 2003 Update: April 2004 Scientific Editor: Doctor Franco Taroni 1Neurogenetics Istituto CSS Mendel, Viale Regina Margherita 261, 00198 Roma, Italy. e.valente@css- mendel.it 2Dipartimento di Medicina Interna, Cardioangiologia ed Epatologia, Università degli studi di Bologna, Laboratorio di Genetica Medica, Policlinico S.Orsola-Malpighi, Via Massarenti 9, 40138 Bologna, Italy.mailto:[email protected] Abstract Keywords Disease name and synonyms Definition Classification Differential diagnosis Prevalence Clinical description Management including treatment Diagnostic methods Etiology Genetic counseling Antenatal diagnosis References Abstract Hereditary spastic paraplegias (HSP) comprise a genetically and clinically heterogeneous group of neurodegenerative disorders characterized by progressive spasticity and hyperreflexia of the lower limbs. Clinically, HSPs can be divided into two main groups: pure and complex forms. Pure HSPs are characterized by slowly progressive lower extremity spasticity and weakness, often associated with hypertonic urinary disturbances, mild reduction of lower extremity vibration sense, and, occasionally, of joint position sensation. Complex HSP forms are characterized by the presence of additional neurological or non-neurological features. Pure HSP is estimated to affect 9.6 individuals in 100.000. HSP may be inherited as an autosomal dominant, autosomal recessive or X-linked recessive trait, and multiple recessive and dominant forms exist. The majority of reported families (70-80%) displays autosomal dominant inheritance, while the remaining cases follow a recessive mode of transmission. To date, 24 different loci responsible for pure and complex HSP have been mapped. Despite the large and increasing number of HSP loci mapped, only 9 autosomal and 2 X-linked genes have been so far identified, and a clear genetic basis for most forms of HSP remains to be elucidated. -
Gene Expression Analysis of Human Induced Pluripotent Stem Cell
Germain et al. Molecular Autism 2014, 5:44 http://www.molecularautism.com/content/5/1/44 RESEARCH Open Access Gene expression analysis of human induced pluripotent stem cell-derived neurons carrying copy number variants of chromosome 15q11-q13.1 Noelle D Germain1, Pin-Fang Chen1, Alex M Plocik1, Heather Glatt-Deeley1, Judith Brown2, James J Fink3, Kaitlyn A Bolduc3, Tiwanna M Robinson3, Eric S Levine3, Lawrence T Reiter4, Brenton R Graveley1,5, Marc Lalande1 and Stormy J Chamberlain1* Abstract Background: Duplications of the chromosome 15q11-q13.1 region are associated with an estimated 1 to 3% of all autism cases, making this copy number variation (CNV) one of the most frequent chromosome abnormalities associated with autism spectrum disorder (ASD). Several genes located within the 15q11-q13.1 duplication region including ubiquitin protein ligase E3A (UBE3A), the gene disrupted in Angelman syndrome (AS), are involved in neural function and may play important roles in the neurobehavioral phenotypes associated with chromosome 15q11-q13.1 duplication (Dup15q) syndrome. Methods: We have generated induced pluripotent stem cell (iPSC) lines from five different individuals containing CNVs of 15q11-q13.1. The iPSC lines were differentiated into mature, functional neurons. Gene expression across the 15q11-q13.1 locus was compared among the five iPSC lines and corresponding iPSC-derived neurons using quantitative reverse transcription PCR (qRT-PCR). Genome-wide gene expression was compared between neurons derived from three iPSC lines using mRNA-Seq. Results: Analysis of 15q11-q13.1 gene expression in neurons derived from Dup15q iPSCs reveals that gene copy number does not consistently predict expression levels in cells with interstitial duplications of 15q11-q13.1. -
A Review of Clinical, Genetic, and Endocrine Findings
J Endocrinol Invest (2015) 38:1249–1263 DOI 10.1007/s40618-015-0312-9 REVIEW Prader‑Willi syndrome: a review of clinical, genetic, and endocrine findings M. A. Angulo1 · M. G. Butler2 · M. E. Cataletto3 Received: 17 March 2015 / Accepted: 11 May 2015 / Published online: 11 June 2015 © The Author(s) 2015. This article is published with open access at Springerlink.com Abstract deficiencies, hypogonadism and central adrenal insuffi- Introduction Prader-Willi syndrome (PWS) is a mul- ciency. Obesity and its complications are the major causes tisystemic complex genetic disorder caused by lack of of morbidity and mortality in PWS. expression of genes on the paternally inherited chromo- Methods An extensive review of the literature was per- some 15q11.2-q13 region. There are three main genetic formed and interpreted within the context of clinical prac- subtypes in PWS: paternal 15q11-q13 deletion (65–75 % tice and frequently asked questions from referring physi- of cases), maternal uniparental disomy 15 (20–30 % of cians and families to include the current status of the cause cases), and imprinting defect (1–3 %). DNA methylation and diagnosis of the clinical, genetics and endocrine find- analysis is the only technique that will diagnose PWS in all ings in PWS. three molecular genetic classes and differentiate PWS from Conclusions Updated information regarding the early Angelman syndrome. Clinical manifestations change with diagnosis and management of individuals with Prader-Willi age with hypotonia and a poor suck resulting in failure to syndrome is important for all physicians and will be helpful thrive during infancy. As the individual ages, other features in anticipating and managing or modifying complications such as short stature, food seeking with excessive weight associated with this rare obesity-related disorder. -
Loss of MAGEL2 in Prader-Willi Syndrome Leads to Decreased Secretory Granule and Neuropeptide Production
Loss of MAGEL2 in Prader-Willi syndrome leads to decreased secretory granule and neuropeptide production Helen Chen, … , Lawrence T. Reiter, Patrick Ryan Potts JCI Insight. 2020;5(17):e138576. https://doi.org/10.1172/jci.insight.138576. Research Article Cell biology Neuroscience Graphical abstract Find the latest version: https://jci.me/138576/pdf RESEARCH ARTICLE Loss of MAGEL2 in Prader-Willi syndrome leads to decreased secretory granule and neuropeptide production Helen Chen,1 A. Kaitlyn Victor,2 Jonathon Klein,1 Klementina Fon Tacer,1 Derek J.C. Tai,3,4,5 Celine de Esch,3,4,5 Alexander Nuttle,3,4,5 Jamshid Temirov,1 Lisa C. Burnett,6,7 Michael Rosenbaum,7 Yiying Zhang,7 Li Ding,8 James J. Moresco,9 Jolene K. Diedrich,9 John R. Yates III,9 Heather S. Tillman,10 Rudolph L. Leibel,7 Michael E. Talkowski,3,4,5 Daniel D. Billadeau,8 Lawrence T. Reiter,2 and Patrick Ryan Potts1 1Department of Cell and Molecular Biology, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA. 2Department of Neurology, Department of Pediatrics, and Department of Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, Tennessee, USA. 3Center for Genomic Medicine, Department of Neurology, Department of Pathology, and Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA. 4Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA. 5Program in Medical and Population Genetics and Stanley Center for Psychiatric Research, Broad Institute, Cambridge, Massachusetts, USA. 6Levo Therapeutics, Inc., Skokie, Illinois, USA. 7Division of Molecular Genetics, Department of Pediatrics, and Naomi Berrie Diabetes Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York, USA. -
Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in -
Chromosomal Microarray Analysis in Turkish Patients with Unexplained Developmental Delay and Intellectual Developmental Disorders
177 Arch Neuropsychitry 2020;57:177−191 RESEARCH ARTICLE https://doi.org/10.29399/npa.24890 Chromosomal Microarray Analysis in Turkish Patients with Unexplained Developmental Delay and Intellectual Developmental Disorders Hakan GÜRKAN1 , Emine İkbal ATLI1 , Engin ATLI1 , Leyla BOZATLI2 , Mengühan ARAZ ALTAY2 , Sinem YALÇINTEPE1 , Yasemin ÖZEN1 , Damla EKER1 , Çisem AKURUT1 , Selma DEMİR1 , Işık GÖRKER2 1Faculty of Medicine, Department of Medical Genetics, Edirne, Trakya University, Edirne, Turkey 2Faculty of Medicine, Department of Child and Adolescent Psychiatry, Trakya University, Edirne, Turkey ABSTRACT Introduction: Aneuploids, copy number variations (CNVs), and single in 39 (39/123=31.7%) patients. Twelve CNV variant of unknown nucleotide variants in specific genes are the main genetic causes of significance (VUS) (9.75%) patients and 7 CNV benign (5.69%) patients developmental delay (DD) and intellectual disability disorder (IDD). were reported. In 6 patients, one or more pathogenic CNVs were These genetic changes can be detected using chromosome analysis, determined. Therefore, the diagnostic efficiency of CMA was found to chromosomal microarray (CMA), and next-generation DNA sequencing be 31.7% (39/123). techniques. Therefore; In this study, we aimed to investigate the Conclusion: Today, genetic analysis is still not part of the routine in the importance of CMA in determining the genomic etiology of unexplained evaluation of IDD patients who present to psychiatry clinics. A genetic DD and IDD in 123 patients. diagnosis from CMA can eliminate genetic question marks and thus Method: For 123 patients, chromosome analysis, DNA fragment analysis alter the clinical management of patients. Approximately one-third and microarray were performed. Conventional G-band karyotype of the positive CMA findings are clinically intervenable. -
Download Ppis for Each Single Seed, Thus Obtaining Each Seed’S Interactome (Ferrari Et Al., 2018)
bioRxiv preprint doi: https://doi.org/10.1101/2021.01.14.425874; this version posted January 16, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Integrating protein networks and machine learning for disease stratification in the Hereditary Spastic Paraplegias Nikoleta Vavouraki1,2, James E. Tomkins1, Eleanna Kara3, Henry Houlden3, John Hardy4, Marcus J. Tindall2,5, Patrick A. Lewis1,4,6, Claudia Manzoni1,7* Author Affiliations 1: Department of Pharmacy, University of Reading, Reading, RG6 6AH, United Kingdom 2: Department of Mathematics and Statistics, University of Reading, Reading, RG6 6AH, United Kingdom 3: Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, United Kingdom 4: Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, WC1N 3BG, United Kingdom 5: Institute of Cardiovascular and Metabolic Research, University of Reading, Reading, RG6 6AS, United Kingdom 6: Department of Comparative Biomedical Sciences, Royal Veterinary College, London, NW1 0TU, United Kingdom 7: School of Pharmacy, University College London, London, WC1N 1AX, United Kingdom *Corresponding author: [email protected] Abstract The Hereditary Spastic Paraplegias are a group of neurodegenerative diseases characterized by spasticity and weakness in the lower body. Despite the identification of causative mutations in over 70 genes, the molecular aetiology remains unclear. Due to the combination of genetic diversity and variable clinical presentation, the Hereditary Spastic Paraplegias are a strong candidate for protein- protein interaction network analysis as a tool to understand disease mechanism(s) and to aid functional stratification of phenotypes. -
Association of NIPA1 Repeat Expansions with Amyotrophic Lateral Sclerosis in a Large International Cohort
Neurobiology of Aging 74 (2019) 234.e9e234.e15 Contents lists available at ScienceDirect Neurobiology of Aging journal homepage: www.elsevier.com/locate/neuaging Association of NIPA1 repeat expansions with amyotrophic lateral sclerosis in a large international cohort Gijs H.P. Tazelaar a,1, Annelot M. Dekker a,1, Joke J.F.A. van Vugt a, Rick A. van der Spek a, Henk-Jan Westeneng a, Lindy J.B.G. Kool a, Kevin P. Kenna a, Wouter van Rheenen a, Sara L. Pulit a, Russell L. McLaughlin b, William Sproviero c, Alfredo Iacoangeli d, Annemarie Hübers e, David Brenner e, Karen E. Morrison f, Pamela J. Shaw g, Christopher E. Shaw g, Monica Povedano Panadés h,i, Jesus S. Mora Pardina j, Jonathan D. Glass k,l, Orla Hardiman m,n, Ammar Al-Chalabi c,o, Philip van Damme p,q,r, Wim Robberecht p,q,r, John E. Landers s, Albert C. Ludolph e, Jochen H. Weishaupt e, Leonard H. van den Berg a, Jan H. Veldink a, Michael A. van Es a,*, on behalf of the Project MinE ALS Sequencing Consortium2 a Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, the Netherlands b Population Genetics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Republic of Ireland c Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute and United Kingdom Dementia Research Institute, King’s College London, London, UK d Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK e Department of Neurology, Ulm -
In Silico Cancer Cell Versus Stroma Cellularity
Yang et al. BMC Medical Genomics 2014, 7(Suppl 1):S2 http://www.biomedcentral.com/1755-8794/7/S1/S2 RESEARCH Open Access In Silico cancer cell versus stroma cellularity index computed from species-specific human and mouse transcriptome of xenograft models: towards accurate stroma targeting therapy assessment Xinan Yang1,6, Yong Huang1, Younghee Lee1, Vincent Gardeux2,3,4,11, Ikbel Achour2,4,11, Kelly Regan2,4, Ellen Rebman2,4, Haiquan Li2,4,11, Yves A Lussier1,2,4,5,7,8,9,10,11* From The 3rd Annual Translational Bioinformatics Conference (TBC/ISCB-Asia 2013) Seoul, Korea. 2-4 October 2013 Abstract Background: The current state of the art for measuring stromal response to targeted therapy requires burdensome and rate limiting quantitative histology. Transcriptome measures are increasingly affordable and provide an opportunity for developing a stromal versus cancer ratio in xenograft models. In these models, human cancer cells are transplanted into mouse host tissues (stroma) and together coevolve into a tumour microenvironment. However, profiling the mouse or human component separately remains problematic. Indeed, laser capture microdissection is labour intensive. Moreover, gene expression using commercial microarrays introduces significant and underreported cross-species hybridization errors that are commonly overlooked by biologists. Method: We developed a customized dual-species array, H&M array, and performed cross-species and species- specific hybridization measurements. We validated a new methodology for establishing the stroma vs cancer ratio using transcriptomic data. Results: In the biological validation of the H&M array, cross-species hybridization of human and mouse probes was significantly reduced (4.5 and 9.4 fold reduction, respectively; p < 2x10-16 for both, Mann-Whitney test).